Literature DB >> 30357502

Epigenetic Alterations in Bladder Cancer.

Sima P Porten1.   

Abstract

PURPOSE OF REVIEW: Epigenetics refers to processes that alter gene expression without altering primary DNA. Over that past decade, there is a growing focus on epigenetic mechanisms in cancer research and its importance in cancer biology. This review summarizes epigenetic dysregulation in bladder cancer. RECENT
FINDINGS: Epigenetic alterations are overall shared across various grades and stages of bladder cancer. High grade invasive tumors demonstrate a greater degree and intensity of methylation and may have a unique methylation pattern. Environmental exposures may influence epigenetic alterations directly independent of genomic change. Non-coding RNAs play an important role in cancer phenotype, especially in the context of integrative genomic analyses. DNA hypermethylation and non-coding RNAs have potential as robust bladder cancer biomarkers; however, they require further study and validation. Changes in chromatin and histone modification are attractive targets for therapy and are currently in clinical trials. Epigenetic dysregulation may be an important key in improving the understanding of bladder cancer pathogenesis, especially through integrative genomic analyses. Deeper understanding of these pathways can help identify clinically relevant biomarkers and therapeutic targets to validate for diagnosis, monitoring, prognosis, and treatment for bladder cancer.

Entities:  

Keywords:  Bladder cancer; Chromatin; Epigenetics; Histones; Methylation; Non-coding RNA

Mesh:

Substances:

Year:  2018        PMID: 30357502     DOI: 10.1007/s11934-018-0861-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  84 in total

1.  Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.

Authors:  Joseph J Fantony; Michael R Abern; Ajay Gopalakrishna; Richmond Owusu; Kae Jack Tay; Raymond S Lance; Brant A Inman
Journal:  Urol Oncol       Date:  2015-05-28       Impact factor: 3.498

2.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.

Authors:  Ewan Birney; John A Stamatoyannopoulos; Anindya Dutta; Roderic Guigó; Thomas R Gingeras; Elliott H Margulies; Zhiping Weng; Michael Snyder; Emmanouil T Dermitzakis; Robert E Thurman; Michael S Kuehn; Christopher M Taylor; Shane Neph; Christoph M Koch; Saurabh Asthana; Ankit Malhotra; Ivan Adzhubei; Jason A Greenbaum; Robert M Andrews; Paul Flicek; Patrick J Boyle; Hua Cao; Nigel P Carter; Gayle K Clelland; Sean Davis; Nathan Day; Pawandeep Dhami; Shane C Dillon; Michael O Dorschner; Heike Fiegler; Paul G Giresi; Jeff Goldy; Michael Hawrylycz; Andrew Haydock; Richard Humbert; Keith D James; Brett E Johnson; Ericka M Johnson; Tristan T Frum; Elizabeth R Rosenzweig; Neerja Karnani; Kirsten Lee; Gregory C Lefebvre; Patrick A Navas; Fidencio Neri; Stephen C J Parker; Peter J Sabo; Richard Sandstrom; Anthony Shafer; David Vetrie; Molly Weaver; Sarah Wilcox; Man Yu; Francis S Collins; Job Dekker; Jason D Lieb; Thomas D Tullius; Gregory E Crawford; Shamil Sunyaev; William S Noble; Ian Dunham; France Denoeud; Alexandre Reymond; Philipp Kapranov; Joel Rozowsky; Deyou Zheng; Robert Castelo; Adam Frankish; Jennifer Harrow; Srinka Ghosh; Albin Sandelin; Ivo L Hofacker; Robert Baertsch; Damian Keefe; Sujit Dike; Jill Cheng; Heather A Hirsch; Edward A Sekinger; Julien Lagarde; Josep F Abril; Atif Shahab; Christoph Flamm; Claudia Fried; Jörg Hackermüller; Jana Hertel; Manja Lindemeyer; Kristin Missal; Andrea Tanzer; Stefan Washietl; Jan Korbel; Olof Emanuelsson; Jakob S Pedersen; Nancy Holroyd; Ruth Taylor; David Swarbreck; Nicholas Matthews; Mark C Dickson; Daryl J Thomas; Matthew T Weirauch; James Gilbert; Jorg Drenkow; Ian Bell; XiaoDong Zhao; K G Srinivasan; Wing-Kin Sung; Hong Sain Ooi; Kuo Ping Chiu; Sylvain Foissac; Tyler Alioto; Michael Brent; Lior Pachter; Michael L Tress; Alfonso Valencia; Siew Woh Choo; Chiou Yu Choo; Catherine Ucla; Caroline Manzano; Carine Wyss; Evelyn Cheung; Taane G Clark; James B Brown; Madhavan Ganesh; Sandeep Patel; Hari Tammana; Jacqueline Chrast; Charlotte N Henrichsen; Chikatoshi Kai; Jun Kawai; Ugrappa Nagalakshmi; Jiaqian Wu; Zheng Lian; Jin Lian; Peter Newburger; Xueqing Zhang; Peter Bickel; John S Mattick; Piero Carninci; Yoshihide Hayashizaki; Sherman Weissman; Tim Hubbard; Richard M Myers; Jane Rogers; Peter F Stadler; Todd M Lowe; Chia-Lin Wei; Yijun Ruan; Kevin Struhl; Mark Gerstein; Stylianos E Antonarakis; Yutao Fu; Eric D Green; Ulaş Karaöz; Adam Siepel; James Taylor; Laura A Liefer; Kris A Wetterstrand; Peter J Good; Elise A Feingold; Mark S Guyer; Gregory M Cooper; George Asimenos; Colin N Dewey; Minmei Hou; Sergey Nikolaev; Juan I Montoya-Burgos; Ari Löytynoja; Simon Whelan; Fabio Pardi; Tim Massingham; Haiyan Huang; Nancy R Zhang; Ian Holmes; James C Mullikin; Abel Ureta-Vidal; Benedict Paten; Michael Seringhaus; Deanna Church; Kate Rosenbloom; W James Kent; Eric A Stone; Serafim Batzoglou; Nick Goldman; Ross C Hardison; David Haussler; Webb Miller; Arend Sidow; Nathan D Trinklein; Zhengdong D Zhang; Leah Barrera; Rhona Stuart; David C King; Adam Ameur; Stefan Enroth; Mark C Bieda; Jonghwan Kim; Akshay A Bhinge; Nan Jiang; Jun Liu; Fei Yao; Vinsensius B Vega; Charlie W H Lee; Patrick Ng; Atif Shahab; Annie Yang; Zarmik Moqtaderi; Zhou Zhu; Xiaoqin Xu; Sharon Squazzo; Matthew J Oberley; David Inman; Michael A Singer; Todd A Richmond; Kyle J Munn; Alvaro Rada-Iglesias; Ola Wallerman; Jan Komorowski; Joanna C Fowler; Phillippe Couttet; Alexander W Bruce; Oliver M Dovey; Peter D Ellis; Cordelia F Langford; David A Nix; Ghia Euskirchen; Stephen Hartman; Alexander E Urban; Peter Kraus; Sara Van Calcar; Nate Heintzman; Tae Hoon Kim; Kun Wang; Chunxu Qu; Gary Hon; Rosa Luna; Christopher K Glass; M Geoff Rosenfeld; Shelley Force Aldred; Sara J Cooper; Anason Halees; Jane M Lin; Hennady P Shulha; Xiaoling Zhang; Mousheng Xu; Jaafar N S Haidar; Yong Yu; Yijun Ruan; Vishwanath R Iyer; Roland D Green; Claes Wadelius; Peggy J Farnham; Bing Ren; Rachel A Harte; Angie S Hinrichs; Heather Trumbower; Hiram Clawson; Jennifer Hillman-Jackson; Ann S Zweig; Kayla Smith; Archana Thakkapallayil; Galt Barber; Robert M Kuhn; Donna Karolchik; Lluis Armengol; Christine P Bird; Paul I W de Bakker; Andrew D Kern; Nuria Lopez-Bigas; Joel D Martin; Barbara E Stranger; Abigail Woodroffe; Eugene Davydov; Antigone Dimas; Eduardo Eyras; Ingileif B Hallgrímsdóttir; Julian Huppert; Michael C Zody; Gonçalo R Abecasis; Xavier Estivill; Gerard G Bouffard; Xiaobin Guan; Nancy F Hansen; Jacquelyn R Idol; Valerie V B Maduro; Baishali Maskeri; Jennifer C McDowell; Morgan Park; Pamela J Thomas; Alice C Young; Robert W Blakesley; Donna M Muzny; Erica Sodergren; David A Wheeler; Kim C Worley; Huaiyang Jiang; George M Weinstock; Richard A Gibbs; Tina Graves; Robert Fulton; Elaine R Mardis; Richard K Wilson; Michele Clamp; James Cuff; Sante Gnerre; David B Jaffe; Jean L Chang; Kerstin Lindblad-Toh; Eric S Lander; Maxim Koriabine; Mikhail Nefedov; Kazutoyo Osoegawa; Yuko Yoshinaga; Baoli Zhu; Pieter J de Jong
Journal:  Nature       Date:  2007-06-14       Impact factor: 49.962

3.  Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.

Authors:  Carmen J Marsit; Margaret R Karagas; Angeline Andrew; Mei Liu; Hadi Danaee; Alan R Schned; Heather H Nelson; Karl T Kelsey
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

4.  ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.

Authors:  Sheila F Faraj; Alcides Chaux; Nilda Gonzalez-Roibon; Enrico Munari; Carla Ellis; Tina Driscoll; Mark P Schoenberg; Trinity J Bivalacqua; Ie-Ming Shih; George J Netto
Journal:  Hum Pathol       Date:  2014-07-23       Impact factor: 3.466

5.  Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.

Authors:  Isabelle Renard; Steven Joniau; Ben van Cleynenbreugel; Catherine Collette; Christophe Naômé; Ilse Vlassenbroeck; Hubert Nicolas; Jean de Leval; Josef Straub; Wim Van Criekinge; Wissem Hamida; Majed Hellel; Alexandre Thomas; Laurence de Leval; Katja Bierau; David Waltregny
Journal:  Eur Urol       Date:  2009-08-05       Impact factor: 20.096

6.  Epigenetic alterations in bladder cancer and their potential clinical implications.

Authors:  Han Han; Erika M Wolff; Gangning Liang
Journal:  Adv Urol       Date:  2012-06-21

Review 7.  Epigenetic therapy in urologic cancers: an update on clinical trials.

Authors:  Inês Faleiro; Ricardo Leão; Alexandra Binnie; Ramon Andrade de Mello; Ana-Teresa Maia; Pedro Castelo-Branco
Journal:  Oncotarget       Date:  2017-02-14

8.  A global profile of gene promoter methylation in treatment-naïve urothelial cancer.

Authors:  Ilsiya Ibragimova; Essel Dulaimi; Michael J Slifker; David Y Chen; Robert G Uzzo; Paul Cairns
Journal:  Epigenetics       Date:  2014-02-12       Impact factor: 4.528

9.  DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells.

Authors:  Christopher E Duymich; Jessica Charlet; Xiaojing Yang; Peter A Jones; Gangning Liang
Journal:  Nat Commun       Date:  2016-04-28       Impact factor: 14.919

10.  Long non‑coding RNA‑GAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (C‑C motif) ligand 1 expression.

Authors:  Qifeng Cao; Ning Wang; Juan Qi; Zhengqin Gu; Haibo Shen
Journal:  Mol Med Rep       Date:  2015-11-05       Impact factor: 2.952

View more
  22 in total

1.  Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns.

Authors:  Huihui Ma; Chenggang Zhao; Zhiyang Zhao; Lizhu Hu; Fang Ye; Hongzhi Wang; Zhiyou Fang; Yuejin Wu; Xueran Chen
Journal:  Cancer Gene Ther       Date:  2019-10-16       Impact factor: 5.987

2.  Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients.

Authors:  Huamei Tang; Lijuan Kan; Tong Ou; Dayang Chen; Xiaowen Dou; Wei Wu; Xiang Ji; Mengmeng Wang; Zengyan Zong; Hongmei Mo; Xiuming Zhang; Dan Xiong
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

3.  High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.

Authors:  Guoliang Wang; Yi Huang; Feilong Yang; Xiaojun Tian; Kun Wang; Li Liu; Yidong Fan; Xiaofeng Li; Luchao Li; Benkang Shi; Yichang Hao; Chuanyou Xia; Qingsheng Nie; Yue Xin; Zhenfeng Shi; Lulin Ma; Dawei Xu; Cheng Liu
Journal:  Aging (Albany NY)       Date:  2020-02-01       Impact factor: 5.682

Review 4.  Targeting the Immune system and Epigenetic Landscape of Urological Tumors.

Authors:  João Lobo; Carmen Jerónimo; Rui Henrique
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

Review 5.  Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet.

Authors:  Victor G Martinez; Ester Munera-Maravilla; Alejandra Bernardini; Carolina Rubio; Cristian Suarez-Cabrera; Cristina Segovia; Iris Lodewijk; Marta Dueñas; Mónica Martínez-Fernández; Jesus Maria Paramio
Journal:  Front Genet       Date:  2019-11-18       Impact factor: 4.599

6.  Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis.

Authors:  Mao Fujimoto; Eri Arai; Koji Tsumura; Takuya Yotani; Yuriko Yamada; Yoriko Takahashi; Akiko Miyagi Maeshima; Hiroyuki Fujimoto; Teruhiko Yoshida; Yae Kanai
Journal:  Epigenetics       Date:  2020-06-04       Impact factor: 4.528

Review 7.  Frontiers in Bladder Cancer Genomic Research.

Authors:  Yi Li; Lihui Sun; Xiangyang Guo; Na Mo; Jinku Zhang; Chong Li
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

Review 8.  DNA Methylation as a Therapeutic Target for Bladder Cancer.

Authors:  Sandra P Nunes; Rui Henrique; Carmen Jerónimo; Jesús M Paramio
Journal:  Cells       Date:  2020-08-07       Impact factor: 6.600

9.  LINC00319-Mediated miR-3127 Repression Enhances Bladder Cancer Progression Through Upregulation of RAP2A.

Authors:  Xiaoqing Wang; Ran Meng; Qing-Mei Hu
Journal:  Front Genet       Date:  2020-03-03       Impact factor: 4.599

10.  A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.

Authors:  Xiang-Hui Ning; Yuan-Yuan Qi; Fang-Xin Wang; Song-Chao Li; Zhan-Kui Jia; Jin-Jian Yang
Journal:  Biomed Res Int       Date:  2020-10-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.